The Molecular Imaging Market is projected to reach $5,437.16 million by 2023 and $15,457.48 million by 2033. The need for early illness diagnosis, particularly related to chronic diseases like cancer, is driving the market growth. Rapid advancements in molecular imaging technologies, such as immune-PET, are improving early cancer cell identification and targeted treatment. Radio-labeled monoclonal antibodies are also being used as molecular imaging biomarkers to assess target expression and tumor targeting. The market is segmented by modality, application, end users, and region. Key players in the market are implementing strategies for growth and development. Future Market Insights (FMI) is a leading provider of market intelligence and advisory services for various industries.
Tue, 05 Sep 2023 12:05:46 GMT | PharmiWeb.com